AI Buyer Insights:

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

List of Advarra OnCore Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight Insight Source
Duke University Health System Healthcare 23462 $4.8B United States Advarra Advarra OnCore Clinical Trial Management 2016 n/a In 2016 Duke University Health System selected Advarra OnCore as its CTMS following a formal contract review that year, launching an enterprise program to standardize clinical trial operations across research units. The selection initiated configuration and program planning that culminated in an enterprise big bang OnCore go live on May 21, 2018. The deployment centered on Advarra OnCore modules for enrollment tracking, study-level reporting, and financial workflow management, with an explicit planned roll out of OnCore Financials. Configuration work addressed accrual and enrollment processes, study financial setups, reporting models, and automation of clinical research administrative workflows consistent with CTMS functional patterns. Advarra OnCore was integrated with Epic for clinical data alignment, with SAP for financial interfacing, and with a new IRB system to centralize regulatory status and approvals. The SAP interfacing work was scoped to improve study financials and reporting by feeding study-level financials into enterprise finance processes. Governance for the deployment centralized research study lifecycle oversight and standardized enrollment tracking, reporting, and financial workflows across Duke research units, with a coordinated enterprise rollout approach. The program documented a staged activation of OnCore Financials and SAP interfaces as part of the broader CTMS implementation and operational handoff to research administration teams.
University of Kentucky Education 13500 $5.5B United States Advarra Advarra OnCore Clinical Trial Management 2006 n/a In 2006 University of Kentucky implemented Advarra OnCore, Apps Category: . The Markey Cancer Center fully implemented the OnCore Enterprise Research System that year to centralize clinical trial management and reporting and to support its National Cancer Institute designation effort. Advarra OnCore was positioned as the authoritative system for protocol tracking and portfolio-level reporting across the cancer center. Implementation emphasis focused on clinical trial management and enterprise reporting, with configuration to centralize protocol lifecycle information and portfolio management data. The deployment consolidated trial status, enrollment tracking, and reporting workflows into Advarra OnCore, and the center documented plans to add biospecimen management functionality within OnCore to extend specimen tracking and inventory oversight. Operational coverage was confined to the Markey Cancer Center within the University of Kentucky, supplying the reporting and portfolio management data used in the NCI application process. Governance changes included centralizing reporting ownership and portfolio oversight in OnCore to support compliance and the NCI submission, and the system helped the center secure NCI designation in 2013.
Yale University Education 14800 $4.2B United States Advarra Advarra OnCore Clinical Trial Management 2013 n/a In 2013, Yale University adopted Advarra OnCore as its institutional CTMS. Yale University implemented Advarra OnCore CTMS to centralize clinical trial management and to support research administration and clinical care coordination across its academic medical enterprise. The deployment emphasized billing and EMR interface capabilities, with Advarra OnCore configured to handle demographics, study status flags, laboratory results, and billing designations. Module usage for billing and EMR interfaces is inferred from the cited case study and institutional documentation, consistent with typical CTMS functional workflows for participant tracking and charge assignment. In 2013 Yale integrated OnCore with its Epic EHR to enable bidirectional data exchange of demographics, study status flags, lab results, and billing designations. The US based integration connected research systems to clinical workflows, improving visibility for care teams and aligning study status and lab data between the CTMS and the electronic health record. Governance and operational alignment routed responsibilities to research administration and clinical informatics groups, ensuring data exchange supported billing compliance and participant safety monitoring. The integration is documented to have improved billing compliance and participant safety visibility across care teams, as reported in institutional materials.
Showing 1 to 3 of 3 entries

Buyer Intent: Companies Evaluating Advarra OnCore

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Advarra OnCore. Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Advarra OnCore Coverage

Advarra OnCore is a Clinical Trial Management solution from Advarra.

Companies worldwide use Advarra OnCore, from small firms to large enterprises across 21+ industries.

Organizations such as University of Kentucky, Duke University Health System and Yale University are recorded users of Advarra OnCore for Clinical Trial Management.

Companies using Advarra OnCore are most concentrated in Education and Healthcare, with adoption spanning over 21 industries.

Companies using Advarra OnCore are most concentrated in United States, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Advarra OnCore across Americas, EMEA, and APAC.

Companies using Advarra OnCore range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 0%, large organizations with 1,001-10,000 employees - 0%, and global enterprises with 10,000+ employees - 100%.

Customers of Advarra OnCore include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Advarra OnCore customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Clinical Trial Management.